These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37988439)

  • 1. Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study.
    Tang GHL; Spencer J; Rogers T; Grubb KJ; Gleason P; Gada H; Mahoney P; Dauerman HL; Forrest JK; Reardon MJ; Blanke P; Leipsic JA; Abdel-Wahab M; Attizzani GF; Puri R; Caskey M; Chung CJ; Chen YH; Dudek D; Allen KB; Chhatriwalla AK; Htun WW; Blackman DJ; Tarantini G; Zhingre Sanchez J; Schwartz G; Popma JJ; Sathananthan J
    Circ Cardiovasc Interv; 2023 Nov; 16(11):e013238. PubMed ID: 37988439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy.
    Grubb KJ; Shekiladze N; Spencer J; Perdoncin E; Tang GHL; Xie J; Lisko J; Sanchez JZ; Lucas LM; Sathananthan J; Rogers T; Deeb GM; Fukuhara S; Blanke P; Leipsic JA; Forrest JK; Reardon MJ; Gleason P
    EuroIntervention; 2023 Jul; 19(4):e330-e339. PubMed ID: 37067193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redo-TAVR Feasibility After SAPIEN 3 Stratified by Implant Depth and Commissural Alignment: A CT Simulation Study.
    Koshy AN; Tang GHL; Khera S; Vinayak M; Berdan M; Gudibendi S; Hooda A; Safi L; Lerakis S; Dangas GD; Sharma SK; Kini AS; Krishnamoorthy P
    Circ Cardiovasc Interv; 2024 Mar; 17(3):e013766. PubMed ID: 38502723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Coronary Obstruction and Feasibility of Coronary Access After Repeat Transcatheter Aortic Valve Replacement With the Self-Expanding Evolut Valve: A Computed Tomography Simulation Study.
    Forrestal BJ; Case BC; Yerasi C; Shea C; Torguson R; Zhang C; Ben-Dor I; Deksissa T; Ali S; Satler LF; Shults C; Weissman G; Wang JC; Khan JM; Waksman R; Rogers T
    Circ Cardiovasc Interv; 2020 Dec; 13(12):e009496. PubMed ID: 33272031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary Access Following Redo TAVR: Impact of THV Design, Implant Technique, and Cell Misalignment.
    Meier D; Akodad M; Landes U; Barlow AM; Chatfield AG; Lai A; Tzimas G; Tang GHL; Puehler T; Lutter G; Leipsic JA; Søndergaard L; Wood DA; Webb JG; Sellers SL; Sathananthan J
    JACC Cardiovasc Interv; 2022 Aug; 15(15):1519-1531. PubMed ID: 35926919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Coronary Obstruction Due to Sinus Sequestration in Redo Transcatheter Aortic Valve Replacement.
    Ochiai T; Oakley L; Sekhon N; Komatsu I; Flint N; Kaewkes D; Yoon SH; Raschpichler M; Patel V; Tiwana R; Enta Y; Mahani S; Kim Y; Stegic J; Chakravarty T; Nakamura M; Cheng W; Makkar R
    JACC Cardiovasc Interv; 2020 Nov; 13(22):2617-2627. PubMed ID: 33213747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary Access After Transcatheter Aortic Valve Replacement With Commissural Alignment: The ALIGN-ACCESS Study.
    Tarantini G; Nai Fovino L; Scotti A; Massussi M; Cardaioli F; Rodinò G; Benedetti A; Boiago M; Matsuda Y; Continisio S; Montonati C; Cacciavillani L; Pavei A; Masiero G; Napodano M; Fraccaro C; Fabris T; Iliceto S
    Circ Cardiovasc Interv; 2022 Feb; 15(2):e011045. PubMed ID: 35167332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap.
    Tang GHL; Zaid S; Fuchs A; Yamabe T; Yazdchi F; Gupta E; Ahmad H; Kofoed KF; Goldberg JB; Undemir C; Kaple RK; Shah PB; Kaneko T; Lansman SL; Khera S; Kovacic JC; Dangas GD; Lerakis S; Sharma SK; Kini A; Adams DH; Khalique OK; Hahn RT; Søndergaard L; George I; Kodali SK; De Backer O; Leon MB; Bapat VN
    JACC Cardiovasc Interv; 2020 May; 13(9):1030-1042. PubMed ID: 32192985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Access After TAVR.
    Ochiai T; Chakravarty T; Yoon SH; Kaewkes D; Flint N; Patel V; Mahani S; Tiwana R; Sekhon N; Nakamura M; Cheng W; Makkar R
    JACC Cardiovasc Interv; 2020 Mar; 13(6):693-705. PubMed ID: 32192689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Redo-Transcatheter Aortic Valve Replacement in Sapien Valves Based on In Vivo Computed Tomography Assessment.
    Fukui M; Okada A; Thao KR; Burns MR; Koike H; Wang C; Phichaphop A; Lesser JR; Sorajja P; Cavalcante JL; Bapat VN
    Circ Cardiovasc Interv; 2023 Nov; 16(11):e013497. PubMed ID: 37988440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights From the BEAT International Collaborative Registrys.
    Mangieri A; Tchetchè D; Kim WK; Pagnesi M; Sinning JM; Landes U; Kornowski R; De Backer O; Nickenig G; Ielasi A; De Biase C; Søndergaard L; De Marco F; Montorfano M; Chiarito M; Regazzoli D; Stefanini G; Presbitero P; Toggweiler S; Tamburino C; Immè S; Tarantini G; Sievert H; Schäfer U; Kempfert J; Wöehrle J; Gallo F; Laricchia A; Latib A; Giannini F; Colombo A
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008714. PubMed ID: 32646304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of High Implantation of Transcatheter Aortic Valve on Subsequent Conduction Disturbances and Coronary Access.
    Ochiai T; Yamanaka F; Shishido K; Moriyama N; Komatsu I; Yokoyama H; Miyashita H; Sato D; Sugiyama Y; Hayashi T; Yamashita T; Tobita K; Matsumoto T; Mizuno S; Tanaka Y; Murakami M; Takahashi S; Makkar R; Saito S
    JACC Cardiovasc Interv; 2023 May; 16(10):1192-1204. PubMed ID: 37225290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed Tomography.
    De Backer O; Landes U; Fuchs A; Yoon SH; Mathiassen ON; Sedaghat A; Kim WK; Pilgrim T; Buzzatti N; Ruile P; El Sabbagh A; Barbanti M; Fiorina C; Nombela-Franco L; Steinvil A; Finkelstein A; Montorfano M; Maurovich-Horvat P; Kofoed KF; Blanke P; Bunc M; Neumann FJ; Latib A; Windecker S; Sinning JM; Norgaard BL; Makkar R; Webb JG; Søndergaard L
    JACC Cardiovasc Interv; 2020 Nov; 13(21):2528-2538. PubMed ID: 33153567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and feasibility of redo-TAVR after Sapien 3 Ultra TAVR in extremely-undersized versus nominally-sized annuli.
    Tang GHL; Hooda A; Zaid S; Chuang MY; Khera S; Krishnamoorthy P; Lerakis S; Anastasius M; Ahmad HA; Goldberg JB; Akodad M; Wood DA; Leipsic JA; Blanke P; Dangas GD; Sharma SK; Kini AS; Webb JG; Sathananthan J
    Catheter Cardiovasc Interv; 2022 May; 99(6):1935-1944. PubMed ID: 35312218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redo-transcatheter aortic valve replacement with the supra-annular, self-expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry.
    Attizzani GF; Dallan LAP; Forrest JK; Reardon MJ; Szeto WY; Liu F; Pelletier M
    Catheter Cardiovasc Interv; 2022 Feb; 99(3):869-876. PubMed ID: 34533891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balloon-Expandable Valve for Treatment of Evolut Valve Failure: Implications on Neoskirt Height and Leaflet Overhang.
    Akodad M; Sellers S; Landes U; Meier D; Tang GHL; Gada H; Rogers T; Caskey M; Rutkin B; Puri R; Rovin J; Leipsic J; Sondergaard L; Grubb KJ; Gleason P; Garde K; Tadros H; Teodoru S; Wood DA; Webb JG; Sathananthan J
    JACC Cardiovasc Interv; 2022 Feb; 15(4):368-377. PubMed ID: 35210043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes of the Self-Expandable Evolut R Valve Versus the Balloon-Expandable SAPIEN 3 Valve in Transcatheter Aortic Valve Implantation: A Meta-Analysis and Systematic Review.
    Al-Abcha A; Saleh Y; Charles L; Prasad R; Baloch ZQ; Hasan MA; Abela GS
    Cardiovasc Revasc Med; 2021 Apr; 25():57-62. PubMed ID: 33160895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Real-World Comparison of 1-Year Survival and Expenditures for Transcatheter Aortic Valve Replacements: SAPIEN 3 Versus CoreValve Versus Evolut R.
    Fukuda H; Kiyohara K; Sato D; Kitamura T; Kodera S
    Value Health; 2021 Apr; 24(4):497-504. PubMed ID: 33840427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary access after repeat transcatheter aortic valve replacement in patients of small body size: A simulation study.
    Kawamura A; Maeda K; Shimamura K; Yamashita K; Mukai T; Nakamura D; Mizote I; Sakata Y; Miyagawa S
    J Thorac Cardiovasc Surg; 2024 Jul; 168(1):76-85.e8. PubMed ID: 36604286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of leaflet splitting on coronary access after redo-TAVI for degenerated supra-annular self-expanding platforms.
    Beneduce A; Khokhar AA; Curio J; Giannini F; Zlahoda-Huzior A; Grant D; Lynch L; Zakrzewski P; Kim WK; Maisano F; de Backer O; Dudek D
    EuroIntervention; 2024 Jun; 20(12):e770-e780. PubMed ID: 38887883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.